
Auteur J. D. JONES
|
Documents disponibles écrits par cet auteur (7)

J. SCOTT ; S. T. SLOMIAK ; J. D. JONES ; A. G. ROSEN ; T. M. MOORE ; R. C. GUR | 2018
Dans JAMA Psychiatry (Vol.75, n°6, June 2018) Article : PériodiqueENGLISH: Importance: Substantial shifts in perception and policy regarding cannabis have recently occurred, with use of cannabis increasing while its perceived harm decreases. One possible risk of increased cannabis use is poorer cognitive func[...]
S. L. WALSH ; S. D. COMER ; M. R. LOFWALL ; B. VINCE ; N. LEVY-COOPERMAN ; D. KELSH ; M. A. COE ; J. D. JONES ; P. A. NUZZO ; F. TIBERG ; B. SHELDON ; S. KIM | 2017
Dans JAMA Psychiatry (Vol.74, n°9, September 2017) Article : PériodiqueImportance: Buprenorphine is an efficacious, widely used treatment for opioid use disorder (OUD). Daily oral transmucosal formulations can be associated with misuse, diversion, and nonadherence; these limitations may be obviated by a sustained r[...]
P. ROUX ; L. FUGON ; J. D. JONES ; S. D. COMER | 2013
Dans American Journal on Addictions (Vol.22, n°6, November-December 2013) Article : PériodiqueBackground and Objectives: In heroin dependent individuals, the HIV epidemic has been controlled in countries where access to opioid maintenance treatment (OMT) and needle exchange programs (NEP) have been implemented. However, despite similar r[...]
J. NEALE ; C. BROWN ; A. N. C. CAMPBELL ; J. D. JONES ; V. E. METZ ; J. STRANG ; S. D. COMER | 2019
Dans Addiction (Vol.114, n°4, April 2019) Article : PériodiqueBACKGROUND AND AIMS: Providing take-home naloxone (THN) to people who use opioids is an increasingly common strategy for reversing opioid overdose. However, implementation is hindered by doubts regarding the ability of people who use opioids to [...]
P. ROUX ; C. TINDALL ; L. FUGON ; J. MURRAY ; S. K. VOSBURG ; P. SACCONE ; M. A. SULLIVAN ; J. M. MANUBAY ; Z. D. COOPER ; J. D. JONES ; R. W. FOLTIN ; S. D. COMER | 2012
Dans Addiction (Vol.107, n°3, March 2012) Article : PériodiqueAims: Research on drug dependence often involves the administration of drugs of abuse to experienced drug users under controlled laboratory conditions. The primary objective of this study was to assess whether participation in such research alte[...]
J. D. JONES ; A. CAMPBELL ; V. E. METZ ; S. D. COMER | 2017
Dans Addictive Behaviors (Vol.71, August 2017) Article : PériodiqueIntroduction: Some fear that distribution of naloxone to persons at risk of experiencing an opioid overdose may reduce the perceived negative consequences of drug use, leading to riskier patterns of use. This study assessed whether participation[...]
J. D. JONES ; S. MOGALI ; S. D. COMER | 2012
Dans Drug and Alcohol Dependence (Vol.125, n°1-2, September 2012) Article : PériodiqueThis paper reviews studies examining the pharmacological interactions and epidemiology of the combined use of opioids and benzodiazepines (BZDs). A search of English language publications from 1970 to 2012 was conducted using PubMed and PsycINFO[...]